Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European Cohort of patients with localized upper tract urothelial carcinoma

Journal of Urology

Volumn 191, Issue 4, 2014, Pages 920-925

  Pichler, Martin ^a   Dalpiaz, Orietta ^a   Ehrlich, Georg C ^a   Stojakovic, Tatjana ^a   Martín Hernández, Jessica M ^a   Mannweiler, Sebastian ^a   Pummer, Karl ^a   Zigeuner, Richard ^a   Hutterer, Georg C ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

carcinoma; fibrinogen; mortality; urinary tract; urothelium

Indexed keywords

FIBRINOGEN; TUMOR MARKER; BIOLOGICAL MARKER;

ACCURACY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; EUROPE; FEMALE; FIBRINOGEN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; UNIVARIATE ANALYSIS; VALIDATION PROCESS; AGE; CONTROLLED STUDY; INTERMEDIATE RISK POPULATION; KIDNEY PELVIS; LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA; LOW RISK POPULATION; LYMPHADENOPATHY; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PROGNOSIS; SEGMENTAL URETERECTOMY; URETER;

CARCINOMA; FIBRINOGEN; MORTALITY; URINARY TRACT; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; EUROPE; FEMALE; FIBRINOGEN; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; URETERAL NEOPLASMS;

EID: 84898425460     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.10.073     Document Type: Article

References (26)

1. M. Rouprêt, R. Zigeuner, and J. Palou et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584
2. A. Jemal, R. Siegel, and E. Ward et al. Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
3. H. Fajkovic, E.K. Cha, and E. Xylinas et al. Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma World J Urol 31 2013 5
4. S.J. Drouin, D.R. Yates, and V. Hupertan et al. A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting World J Urol 31 2013 109
5. M. Rouprêt, V. Hupertan, and T. Seisen et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis J Urol 189 2013 1662
6. R. Zigeuner, S.F. Shariat, and V. Margulis et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract Eur Urol 57 2010 575
7. C. Seitz, A. Gupta, and S.F. Shariat et al. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study J Urol 184 2010 1895
8. V. Margulis, R.F. Youssef, and P.I. Karakiewicz et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract J Urol 184 2010 453
9. C.S. Roxburgh, J.E. Crozier, and F. Maxwell et al. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer Br J Cancer 100 2009 701
10. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860
11. M. Pichler, G.C. Hutterer, and C. Stoeckigt et al. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients Br J Cancer 108 2013 901
12. M. Pichler, G.C. Hutterer, and T. Stojakovic et al. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients Br J Cancer 109 2013 1123
13. A. Sahni, P.J. Simpson-Haidaris, and S.K. Sahni et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2) J Thromb Haemost 6 2008 176
14. S. Polterauer, C. Grimm, and V. Seebacher et al. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study Oncologist 14 2009 979
15. V. Seebacher, S. Polterauer, and C. Grimm et al. The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial Br J Cancer 102 2010 952
16. L. Tang, K. Liu, and J. Wang et al. High preoperative plasma fibrinogen levels are associated with distant metastases and impaired prognosis after curative resection in patients with colorectal cancer J Surg Oncol 102 2010 428
17. N. Tanaka, E. Kikuchi, and K. Matsumoto et al. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma BJU Int 111 2013 857
18. International Union Against Cancer: Urological tumours: renal pelvis and ureter. In: TNM Classification of Malignant Tumours, 7th ed revised. Edited by LH Sobin, M Gospodarowicz and C Wittekind. New York: Wiley-Liss Blackwell 2009; pp 258-261.
19. Dalpiaz O, Ehrlich GC, Mannweiler SM, et al. Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. BJU Int 2013. Epub ahead of print.
20. Y. Ohno, J. Nakashima, and M. Ohori et al. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma J Urol 184 2010 873
21. S.E. Bleeker, H.A. Moll, and E.W. Steyerberg et al. External validation is necessary in prediction research: a clinical example J Clin Epidemiol 56 2003 826
22. J.S. Palumbo, K.W. Kombrinck, and A.F. Drew et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells Blood 96 2000 3302
23. S. Zheng, J. Shen, and Y. Jiao et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity Cancer Sci 100 2009 859
24. Y. Roche, D. Pasquier, and J.J. Rambeaud et al. Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway Thromb Haemost 89 2003 1089
25. V. Tiedje, D. Dunkler, and C. Ay et al. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis Thromb Haemost 106 2011 908
26. S.W. Song, H.S. Lee, and M.S. Kim et al. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection Ann Thorac Surg 81 2006 1974